Delivery Order SPE2DB20D1100-SPE2DB25FB9G6
Award Date 4/24/25
Potential Completion Date 5/15/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,334.66 to AmerisourceBergen Drug Corp for ATTRUBY 356 mg tablets (28 count) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The pharmaceutical supply will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $12.78K delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count units) under a firm fixed-price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,778.22 to AmerisourceBergen Drug Corp for the supply of Attruby 356 mg tablets (28-count package). This firm fixed-price, competitively awarded delivery order was executed on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is a firm fixed-price delivery order for the supply of ATTRUBY 356 MG TABLET 28S medical products. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $37,266.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $12.78K delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $1 billion through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,064.80 to AmerisourceBergen Drug Corp on August 2, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999.99M and extends through December 2026. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $14,731.84 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award (Contract No. 4568975942) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The contract will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...